The applications aim to launch Phase Ib/II trials for relapsed/refractory multiple myeloma and primary plasma cell leukemia, respectively
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
The approval follows results from the DESTINY-Breast06 phase 3 trial, which showed ENHERTU significantly extended progression-free survival compared to chemotherapy
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
Full approval will depend on verification of clinical benefit in a confirmatory trial
Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
FOP is a rare genetic disorder caused by mutations in the ALK2 kinase
The initiative is focused on a problem that continues to plague cancer outcomes in India
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Subscribe To Our Newsletter & Stay Updated
